“cancer-immunotherapy” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity 10/02/20 National
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase 09/04/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Page 1 of 9 next page »